meperidine has been researched along with sphingosine kinase in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aoyama, Y; Ichihara, M; Inoue, C; Kawamoto, Y; Kyogashima, M; Mizutani, N; Murate, T; Nishizawa, Y; Nozawa, Y; Sobue, S; Suzuki, M | 1 |
1 other study(ies) available for meperidine and sphingosine kinase
Article | Year |
---|---|
Modulation of the sphingolipid rheostat is involved in paclitaxel resistance of the human prostate cancer cell line PC3-PR.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Enzyme Inhibitors; Epithelial Cells; Gene Expression Regulation, Neoplastic; Glucosyltransferases; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; K562 Cells; Male; Meperidine; Morpholines; Paclitaxel; Phosphotransferases (Alcohol Group Acceptor); Prostate; Proteasome Endopeptidase Complex; Proteasome Inhibitors; RNA, Small Interfering; Sp1 Transcription Factor; Sphingolipids; Sphingomyelin Phosphodiesterase | 2017 |